Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Soluble CD163 and monocyte populations in response to antiretroviral therapy and in relationship with neuropsychological testing among HIV-infected children.

Ananworanich J, Kerr SJ, Jaimulwong T, Vibol U, Hansudewechakul R, Kosalaraksa P, Ngampiyaskul C, Kanjanavanit S, Wongsawat J, Luesomboon W, Apornpong T, Soulas C, Paul R, Ruxrungtham K, Puthanakit T.

J Virus Erad. 2015;1(3):196-202. Epub 2015 Jun 30.

2.

Increased Expression of CD169 on Blood Monocytes and Its Regulation by Virus and CD8 T Cells in Macaque Models of HIV Infection and AIDS.

Kim WK, McGary CM, Holder GE, Filipowicz AR, Kim MM, Beydoun HA, Cai Y, Liu X, Sugimoto C, Kuroda MJ.

AIDS Res Hum Retroviruses. 2015 Jul;31(7):696-706. doi: 10.1089/AID.2015.0003. Epub 2015 May 11.

PMID:
25891017
3.

Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes.

Carvallo L, Lopez L, Che FY, Lim J, Eugenin EA, Williams DW, Nieves E, Calderon TM, Madrid-Aliste C, Fiser A, Weiss L, Angeletti RH, Berman JW.

J Immunol. 2015 Apr 1;194(7):3246-58. doi: 10.4049/jimmunol.1302647. Epub 2015 Feb 25.

PMID:
25716997
4.

Brain alterations within the first 100 days of HIV infection.

Ragin AB, Wu Y, Gao Y, Keating S, Du H, Sammet C, Kettering CS, Epstein LG.

Ann Clin Transl Neurol. 2015 Jan;2(1):12-21. doi: 10.1002/acn3.136. Epub 2014 Dec 18.

5.

Spatiotemporal dynamics of simian immunodeficiency virus brain infection in CD8+ lymphocyte-depleted rhesus macaques with neuroAIDS.

Strickland SL, Rife BD, Lamers SL, Nolan DJ, Veras NM, Prosperi MC, Burdo TH, Autissier P, Nowlin B, Goodenow MM, Suchard MA, Williams KC, Salemi M.

J Gen Virol. 2014 Dec;95(Pt 12):2784-95. doi: 10.1099/vir.0.070318-0. Epub 2014 Sep 9.

6.

Three-dimensional imaging of HIV-1 virological synapses reveals membrane architectures involved in virus transmission.

Do T, Murphy G, Earl LA, Del Prete GQ, Grandinetti G, Li GH, Estes JD, Rao P, Trubey CM, Thomas J, Spector J, Bliss D, Nath A, Lifson JD, Subramaniam S.

J Virol. 2014 Sep;88(18):10327-39. doi: 10.1128/JVI.00788-14. Epub 2014 Jun 25.

7.

Nanoscale drug delivery systems and the blood-brain barrier.

Alyautdin R, Khalin I, Nafeeza MI, Haron MH, Kuznetsov D.

Int J Nanomedicine. 2014 Feb 7;9:795-811. doi: 10.2147/IJN.S52236. eCollection 2014. Review.

8.

Monocyte/macrophages and their role in HIV neuropathogenesis.

Burdo TH, Lackner A, Williams KC.

Immunol Rev. 2013 Jul;254(1):102-13. doi: 10.1111/imr.12068. Review.

9.

Impaired learning resulting from respiratory syncytial virus infection.

Espinoza JA, Bohmwald K, Céspedes PF, Gómez RS, Riquelme SA, Cortés CM, Valenzuela JA, Sandoval RA, Pancetti FC, Bueno SM, Riedel CA, Kalergis AM.

Proc Natl Acad Sci U S A. 2013 May 28;110(22):9112-7. doi: 10.1073/pnas.1217508110. Epub 2013 May 6.

10.

Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progression.

Breed MW, Jordan AP, Aye PP, Lichtveld CF, Midkiff CC, Schiro FR, Haggarty BS, Sugimoto C, Alvarez X, Sandler NG, Douek DC, Kuroda MJ, Pahar B, Piatak M Jr, Lifson JD, Keele BF, Hoxie JA, Lackner AA.

J Virol. 2013 Feb;87(3):1528-43. doi: 10.1128/JVI.01928-12. Epub 2012 Nov 14.

11.

Substance abuse, HIV-1 and hepatitis.

Parikh N, Nonnemacher MR, Pirrone V, Block T, Mehta A, Wigdahl B.

Curr HIV Res. 2012 Oct;10(7):557-71. Review.

12.

The Impact of Macrophage Nucleotide Pools on HIV-1 Reverse Transcription, Viral Replication, and the Development of Novel Antiviral Agents.

Gavegnano C, Kennedy EM, Kim B, Schinazi RF.

Mol Biol Int. 2012;2012:625983. doi: 10.1155/2012/625983. Epub 2012 Jul 1.

13.

Cognitive performance related to HIV-1-infected monocytes.

Kusao I, Shiramizu B, Liang CY, Grove J, Agsalda M, Troelstrup D, Velasco VN, Marshall A, Whitenack N, Shikuma C, Valcour V.

J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):71-80. doi: 10.1176/appi.neuropsych.11050109.

14.

Regional cortical thinning associated with detectable levels of HIV DNA.

Kallianpur KJ, Kirk GR, Sailasuta N, Valcour V, Shiramizu B, Nakamoto BK, Shikuma C.

Cereb Cortex. 2012 Sep;22(9):2065-75. doi: 10.1093/cercor/bhr285. Epub 2011 Oct 19.

15.

Brain cell reservoirs of latent virus in presymptomatic HIV-infected individuals.

Thompson KA, Cherry CL, Bell JE, McLean CA.

Am J Pathol. 2011 Oct;179(4):1623-9. doi: 10.1016/j.ajpath.2011.06.039. Epub 2011 Aug 24.

16.

Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV neuroAIDS.

Campbell JH, Burdo TH, Autissier P, Bombardier JP, Westmoreland SV, Soulas C, González RG, Ratai EM, Williams KC.

PLoS One. 2011 Apr 6;6(4):e18688. doi: 10.1371/journal.pone.0018688.

17.

Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS.

Buckner CM, Calderon TM, Willams DW, Belbin TJ, Berman JW.

Cell Immunol. 2011;267(2):109-23. doi: 10.1016/j.cellimm.2010.12.004. Epub 2010 Dec 25.

18.

Proteomic analysis of HIV-infected macrophages.

Meléndez LM, Colon K, Rivera L, Rodriguez-Franco E, Toro-Nieves D.

J Neuroimmune Pharmacol. 2011 Mar;6(1):89-106. doi: 10.1007/s11481-010-9253-4. Epub 2010 Dec 14. Review.

19.

HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues.

Lamers SL, Gray RR, Salemi M, Huysentruyt LC, McGrath MS.

Infect Genet Evol. 2011 Jan;11(1):31-7. doi: 10.1016/j.meegid.2010.10.016. Epub 2010 Nov 3.

20.

Immunophenotyping of lymphocyte, monocyte and dendritic cell subsets in normal rhesus macaques by 12-color flow cytometry: clarification on DC heterogeneity.

Autissier P, Soulas C, Burdo TH, Williams KC.

J Immunol Methods. 2010 Aug 31;360(1-2):119-28. doi: 10.1016/j.jim.2010.06.017. Epub 2010 Jun 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk